カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

顔面紅斑治療薬の世界市場2022：Rx、OTC

■ 英語タイトル：Global Drugs for Facial Erythema Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22DC3791）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22DC3791
■ 発行日：2023年1月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：90
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[顔面紅斑治療薬の世界市場2022：Rx、OTC]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

世界の顔面紅斑治療薬市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界の顔面紅斑治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

顔面紅斑治療薬市場はタイプとアプリケーションによって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・Rx、OTC

アプリケーション別セグメントは次のように区分されます。
・病院、診療所、その他

世界の顔面紅斑治療薬市場の主要な市場プレーヤーは以下のとおりです。
・Novartis、Pfizer、Sanofi-Aventis、Merck、Enzon Pharmaceuticals、Bayer、Astellas Pharma、GSK、Abbott

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、顔面紅斑治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な顔面紅斑治療薬メーカーの企業概要、2019年～2022年までの顔面紅斑治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な顔面紅斑治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別顔面紅斑治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの顔面紅斑治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での顔面紅斑治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および顔面紅斑治療薬の産業チェーンを掲載しています。
・第13、14、15章では、顔面紅斑治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– 顔面紅斑治療薬の概要
– 種類別分析（2017年vs2021年vs2028年）：Rx、OTC
– 用途別分析（2017年vs2021年vs2028年）：病院、診療所、その他
– 世界の顔面紅斑治療薬市場規模・予測
– 世界の顔面紅斑治療薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Novartis、Pfizer、Sanofi-Aventis、Merck、Enzon Pharmaceuticals、Bayer、Astellas Pharma、GSK、Abbott
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：Rx、OTC
・用途別分析2017年-2028年：病院、診療所、その他
・顔面紅斑治療薬の北米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・顔面紅斑治療薬のヨーロッパ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・顔面紅斑治療薬のアジア市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・顔面紅斑治療薬の南米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・顔面紅斑治療薬の中東・アフリカ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Drugs for Facial Erythema Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drugs for Facial Erythema Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Rx
1.2.3 OTC
1.3 Market Analysis by Application
1.3.1 Overview: Global Drugs for Facial Erythema Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Drugs for Facial Erythema Market Size & Forecast
1.4.1 Global Drugs for Facial Erythema Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Drugs for Facial Erythema Sales in Volume (2017-2028)
1.4.3 Global Drugs for Facial Erythema Price (2017-2028)
1.5 Global Drugs for Facial Erythema Production Capacity Analysis
1.5.1 Global Drugs for Facial Erythema Total Production Capacity (2017-2028)
1.5.2 Global Drugs for Facial Erythema Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Drugs for Facial Erythema Market Drivers
1.6.2 Drugs for Facial Erythema Market Restraints
1.6.3 Drugs for Facial Erythema Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Drugs for Facial Erythema Product and Services
2.1.4 Novartis Drugs for Facial Erythema Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Drugs for Facial Erythema Product and Services
2.2.4 Pfizer Drugs for Facial Erythema Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sanofi-Aventis
2.3.1 Sanofi-Aventis Details
2.3.2 Sanofi-Aventis Major Business
2.3.3 Sanofi-Aventis Drugs for Facial Erythema Product and Services
2.3.4 Sanofi-Aventis Drugs for Facial Erythema Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Drugs for Facial Erythema Product and Services
2.4.4 Merck Drugs for Facial Erythema Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Enzon Pharmaceuticals
2.5.1 Enzon Pharmaceuticals Details
2.5.2 Enzon Pharmaceuticals Major Business
2.5.3 Enzon Pharmaceuticals Drugs for Facial Erythema Product and Services
2.5.4 Enzon Pharmaceuticals Drugs for Facial Erythema Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Bayer
2.6.1 Bayer Details
2.6.2 Bayer Major Business
2.6.3 Bayer Drugs for Facial Erythema Product and Services
2.6.4 Bayer Drugs for Facial Erythema Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Astellas Pharma
2.7.1 Astellas Pharma Details
2.7.2 Astellas Pharma Major Business
2.7.3 Astellas Pharma Drugs for Facial Erythema Product and Services
2.7.4 Astellas Pharma Drugs for Facial Erythema Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 GSK
2.8.1 GSK Details
2.8.2 GSK Major Business
2.8.3 GSK Drugs for Facial Erythema Product and Services
2.8.4 GSK Drugs for Facial Erythema Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Abbott
2.9.1 Abbott Details
2.9.2 Abbott Major Business
2.9.3 Abbott Drugs for Facial Erythema Product and Services
2.9.4 Abbott Drugs for Facial Erythema Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Drugs for Facial Erythema Breakdown Data by Manufacturer
3.1 Global Drugs for Facial Erythema Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Drugs for Facial Erythema Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Drugs for Facial Erythema
3.4 Market Concentration Rate
3.4.1 Top 3 Drugs for Facial Erythema Manufacturer Market Share in 2021
3.4.2 Top 6 Drugs for Facial Erythema Manufacturer Market Share in 2021
3.5 Global Drugs for Facial Erythema Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Drugs for Facial Erythema Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Drugs for Facial Erythema Market Size by Region
4.1.1 Global Drugs for Facial Erythema Sales in Volume by Region (2017-2028)
4.1.2 Global Drugs for Facial Erythema Revenue by Region (2017-2028)
4.2 North America Drugs for Facial Erythema Revenue (2017-2028)
4.3 Europe Drugs for Facial Erythema Revenue (2017-2028)
4.4 Asia-Pacific Drugs for Facial Erythema Revenue (2017-2028)
4.5 South America Drugs for Facial Erythema Revenue (2017-2028)
4.6 Middle East and Africa Drugs for Facial Erythema Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Drugs for Facial Erythema Sales in Volume by Type (2017-2028)
5.2 Global Drugs for Facial Erythema Revenue by Type (2017-2028)
5.3 Global Drugs for Facial Erythema Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Drugs for Facial Erythema Sales in Volume by Application (2017-2028)
6.2 Global Drugs for Facial Erythema Revenue by Application (2017-2028)
6.3 Global Drugs for Facial Erythema Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Drugs for Facial Erythema Sales by Type (2017-2028)
7.2 North America Drugs for Facial Erythema Sales by Application (2017-2028)
7.3 North America Drugs for Facial Erythema Market Size by Country
7.3.1 North America Drugs for Facial Erythema Sales in Volume by Country (2017-2028)
7.3.2 North America Drugs for Facial Erythema Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Drugs for Facial Erythema Sales by Type (2017-2028)
8.2 Europe Drugs for Facial Erythema Sales by Application (2017-2028)
8.3 Europe Drugs for Facial Erythema Market Size by Country
8.3.1 Europe Drugs for Facial Erythema Sales in Volume by Country (2017-2028)
8.3.2 Europe Drugs for Facial Erythema Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Drugs for Facial Erythema Sales by Type (2017-2028)
9.2 Asia-Pacific Drugs for Facial Erythema Sales by Application (2017-2028)
9.3 Asia-Pacific Drugs for Facial Erythema Market Size by Region
9.3.1 Asia-Pacific Drugs for Facial Erythema Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Drugs for Facial Erythema Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Drugs for Facial Erythema Sales by Type (2017-2028)
10.2 South America Drugs for Facial Erythema Sales by Application (2017-2028)
10.3 South America Drugs for Facial Erythema Market Size by Country
10.3.1 South America Drugs for Facial Erythema Sales in Volume by Country (2017-2028)
10.3.2 South America Drugs for Facial Erythema Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Drugs for Facial Erythema Sales by Type (2017-2028)
11.2 Middle East & Africa Drugs for Facial Erythema Sales by Application (2017-2028)
11.3 Middle East & Africa Drugs for Facial Erythema Market Size by Country
11.3.1 Middle East & Africa Drugs for Facial Erythema Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Drugs for Facial Erythema Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Drugs for Facial Erythema and Key Manufacturers
12.2 Manufacturing Costs Percentage of Drugs for Facial Erythema
12.3 Drugs for Facial Erythema Production Process
12.4 Drugs for Facial Erythema Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Drugs for Facial Erythema Typical Distributors
13.3 Drugs for Facial Erythema Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Drugs for Facial Erythema Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Drugs for Facial Erythema Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Drugs for Facial Erythema Product and Services
Table 6. Novartis Drugs for Facial Erythema Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Drugs for Facial Erythema Product and Services
Table 10. Pfizer Drugs for Facial Erythema Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi-Aventis Major Business
Table 13. Sanofi-Aventis Drugs for Facial Erythema Product and Services
Table 14. Sanofi-Aventis Drugs for Facial Erythema Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Drugs for Facial Erythema Product and Services
Table 18. Merck Drugs for Facial Erythema Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Enzon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Enzon Pharmaceuticals Major Business
Table 21. Enzon Pharmaceuticals Drugs for Facial Erythema Product and Services
Table 22. Enzon Pharmaceuticals Drugs for Facial Erythema Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Bayer Basic Information, Manufacturing Base and Competitors
Table 24. Bayer Major Business
Table 25. Bayer Drugs for Facial Erythema Product and Services
Table 26. Bayer Drugs for Facial Erythema Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 28. Astellas Pharma Major Business
Table 29. Astellas Pharma Drugs for Facial Erythema Product and Services
Table 30. Astellas Pharma Drugs for Facial Erythema Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. GSK Basic Information, Manufacturing Base and Competitors
Table 32. GSK Major Business
Table 33. GSK Drugs for Facial Erythema Product and Services
Table 34. GSK Drugs for Facial Erythema Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Abbott Basic Information, Manufacturing Base and Competitors
Table 36. Abbott Major Business
Table 37. Abbott Drugs for Facial Erythema Product and Services
Table 38. Abbott Drugs for Facial Erythema Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Drugs for Facial Erythema Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Drugs for Facial Erythema Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Drugs for Facial Erythema, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Drugs for Facial Erythema Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Drugs for Facial Erythema Production Site of Key Manufacturer
Table 44. Drugs for Facial Erythema New Entrant and Capacity Expansion Plans
Table 45. Drugs for Facial Erythema Mergers & Acquisitions in the Past Five Years
Table 46. Global Drugs for Facial Erythema Sales by Region (2017-2022) & (K Units)
Table 47. Global Drugs for Facial Erythema Sales by Region (2023-2028) & (K Units)
Table 48. Global Drugs for Facial Erythema Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Drugs for Facial Erythema Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Drugs for Facial Erythema Sales by Type (2017-2022) & (K Units)
Table 51. Global Drugs for Facial Erythema Sales by Type (2023-2028) & (K Units)
Table 52. Global Drugs for Facial Erythema Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Drugs for Facial Erythema Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Drugs for Facial Erythema Price by Type (2017-2022) & (USD/Unit)
Table 55. Global Drugs for Facial Erythema Price by Type (2023-2028) & (USD/Unit)
Table 56. Global Drugs for Facial Erythema Sales by Application (2017-2022) & (K Units)
Table 57. Global Drugs for Facial Erythema Sales by Application (2023-2028) & (K Units)
Table 58. Global Drugs for Facial Erythema Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Drugs for Facial Erythema Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Drugs for Facial Erythema Price by Application (2017-2022) & (USD/Unit)
Table 61. Global Drugs for Facial Erythema Price by Application (2023-2028) & (USD/Unit)
Table 62. North America Drugs for Facial Erythema Sales by Country (2017-2022) & (K Units)
Table 63. North America Drugs for Facial Erythema Sales by Country (2023-2028) & (K Units)
Table 64. North America Drugs for Facial Erythema Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Drugs for Facial Erythema Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Drugs for Facial Erythema Sales by Type (2017-2022) & (K Units)
Table 67. North America Drugs for Facial Erythema Sales by Type (2023-2028) & (K Units)
Table 68. North America Drugs for Facial Erythema Sales by Application (2017-2022) & (K Units)
Table 69. North America Drugs for Facial Erythema Sales by Application (2023-2028) & (K Units)
Table 70. Europe Drugs for Facial Erythema Sales by Country (2017-2022) & (K Units)
Table 71. Europe Drugs for Facial Erythema Sales by Country (2023-2028) & (K Units)
Table 72. Europe Drugs for Facial Erythema Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Drugs for Facial Erythema Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Drugs for Facial Erythema Sales by Type (2017-2022) & (K Units)
Table 75. Europe Drugs for Facial Erythema Sales by Type (2023-2028) & (K Units)
Table 76. Europe Drugs for Facial Erythema Sales by Application (2017-2022) & (K Units)
Table 77. Europe Drugs for Facial Erythema Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Drugs for Facial Erythema Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Drugs for Facial Erythema Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Drugs for Facial Erythema Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Drugs for Facial Erythema Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Drugs for Facial Erythema Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Drugs for Facial Erythema Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Drugs for Facial Erythema Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Drugs for Facial Erythema Sales by Application (2023-2028) & (K Units)
Table 86. South America Drugs for Facial Erythema Sales by Country (2017-2022) & (K Units)
Table 87. South America Drugs for Facial Erythema Sales by Country (2023-2028) & (K Units)
Table 88. South America Drugs for Facial Erythema Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Drugs for Facial Erythema Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Drugs for Facial Erythema Sales by Type (2017-2022) & (K Units)
Table 91. South America Drugs for Facial Erythema Sales by Type (2023-2028) & (K Units)
Table 92. South America Drugs for Facial Erythema Sales by Application (2017-2022) & (K Units)
Table 93. South America Drugs for Facial Erythema Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Drugs for Facial Erythema Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Drugs for Facial Erythema Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Drugs for Facial Erythema Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Drugs for Facial Erythema Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Drugs for Facial Erythema Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Drugs for Facial Erythema Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Drugs for Facial Erythema Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Drugs for Facial Erythema Sales by Application (2023-2028) & (K Units)
Table 102. Drugs for Facial Erythema Raw Material
Table 103. Key Manufacturers of Drugs for Facial Erythema Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Drugs for Facial Erythema Typical Distributors
Table 107. Drugs for Facial Erythema Typical Customers
List of Figures
Figure 1. Drugs for Facial Erythema Picture
Figure 2. Global Drugs for Facial Erythema Revenue Market Share by Type in 2021
Figure 3. Rx
Figure 4. OTC
Figure 5. Global Drugs for Facial Erythema Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Global Drugs for Facial Erythema Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Drugs for Facial Erythema Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Drugs for Facial Erythema Sales (2017-2028) & (K Units)
Figure 12. Global Drugs for Facial Erythema Price (2017-2028) & (USD/Unit)
Figure 13. Global Drugs for Facial Erythema Production Capacity (2017-2028) & (K Units)
Figure 14. Global Drugs for Facial Erythema Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Drugs for Facial Erythema Market Drivers
Figure 16. Drugs for Facial Erythema Market Restraints
Figure 17. Drugs for Facial Erythema Market Trends
Figure 18. Global Drugs for Facial Erythema Sales Market Share by Manufacturer in 2021
Figure 19. Global Drugs for Facial Erythema Revenue Market Share by Manufacturer in 2021
Figure 20. Drugs for Facial Erythema Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Drugs for Facial Erythema Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Drugs for Facial Erythema Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Drugs for Facial Erythema Sales Market Share by Region (2017-2028)
Figure 24. Global Drugs for Facial Erythema Revenue Market Share by Region (2017-2028)
Figure 25. North America Drugs for Facial Erythema Revenue (2017-2028) & (USD Million)
Figure 26. Europe Drugs for Facial Erythema Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Drugs for Facial Erythema Revenue (2017-2028) & (USD Million)
Figure 28. South America Drugs for Facial Erythema Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Drugs for Facial Erythema Revenue (2017-2028) & (USD Million)
Figure 30. Global Drugs for Facial Erythema Sales Market Share by Type (2017-2028)
Figure 31. Global Drugs for Facial Erythema Revenue Market Share by Type (2017-2028)
Figure 32. Global Drugs for Facial Erythema Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Drugs for Facial Erythema Sales Market Share by Application (2017-2028)
Figure 34. Global Drugs for Facial Erythema Revenue Market Share by Application (2017-2028)
Figure 35. Global Drugs for Facial Erythema Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Drugs for Facial Erythema Sales Market Share by Type (2017-2028)
Figure 37. North America Drugs for Facial Erythema Sales Market Share by Application (2017-2028)
Figure 38. North America Drugs for Facial Erythema Sales Market Share by Country (2017-2028)
Figure 39. North America Drugs for Facial Erythema Revenue Market Share by Country (2017-2028)
Figure 40. United States Drugs for Facial Erythema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Drugs for Facial Erythema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Drugs for Facial Erythema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Drugs for Facial Erythema Sales Market Share by Type (2017-2028)
Figure 44. Europe Drugs for Facial Erythema Sales Market Share by Application (2017-2028)
Figure 45. Europe Drugs for Facial Erythema Sales Market Share by Country (2017-2028)
Figure 46. Europe Drugs for Facial Erythema Revenue Market Share by Country (2017-2028)
Figure 47. Germany Drugs for Facial Erythema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Drugs for Facial Erythema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Drugs for Facial Erythema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Drugs for Facial Erythema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Drugs for Facial Erythema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Drugs for Facial Erythema Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Drugs for Facial Erythema Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Drugs for Facial Erythema Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Drugs for Facial Erythema Revenue Market Share by Region (2017-2028)
Figure 56. China Drugs for Facial Erythema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Drugs for Facial Erythema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Drugs for Facial Erythema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Drugs for Facial Erythema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Drugs for Facial Erythema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Drugs for Facial Erythema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Drugs for Facial Erythema Sales Market Share by Type (2017-2028)
Figure 63. South America Drugs for Facial Erythema Sales Market Share by Application (2017-2028)
Figure 64. South America Drugs for Facial Erythema Sales Market Share by Country (2017-2028)
Figure 65. South America Drugs for Facial Erythema Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Drugs for Facial Erythema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Drugs for Facial Erythema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Drugs for Facial Erythema Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Drugs for Facial Erythema Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Drugs for Facial Erythema Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Drugs for Facial Erythema Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Drugs for Facial Erythema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Drugs for Facial Erythema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Drugs for Facial Erythema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Drugs for Facial Erythema Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Drugs for Facial Erythema in 2021
Figure 77. Manufacturing Process Analysis of Drugs for Facial Erythema
Figure 78. Drugs for Facial Erythema Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 顔面紅斑用医薬品の世界市場2022：Rx、OTC
  • 顔面紅斑治療薬のグローバル市場展望 2023年-2029年：Rx、OTC
  • 顔面紅斑治療のグローバル市場展望 2023年-2029年：Rx、OTC
  • シグニフォー医薬品の世界市場2022：0.3mg/ml、0.6mg/ml、0.9mg/ml
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22DC3791 )"顔面紅斑治療薬の世界市場2022：Rx、OTC" (英文：Global Drugs for Facial Erythema Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。